Cardiac inflammation biomarker test company Cleveland HeartLab has been tapped as the Ohio Venture Association‘s “venture of the year.”
The last year has been an eventful one for the Cleveland-based company: It spurned a buyout offer from an unidentified Massachusetts suitor, closed an $18.4 million series B round of investment, moved into a new building that quadrupled its office space, made a splash at TEDMED and is eyeing a new market — health and wellness.
In only two-and-a-half years since its launch, the company has grown from eight employees to about 110.
Jim Weisman, president of the Ohio Venture Association (OVA), called HeartLab “the best emerging company in Northeast Ohio.”
“Management has positioned the company for continued growth and value creation, properly harnessing one of the biggest challenges that often dooms early stage companies — success,” Weisman said.
Cleveland HeartLab CEO Jake Orville is scheduled to accept the award at tomorrow’s OVA luncheon in downtown Cleveland.
